Caroline Corner | Westwicke, Investor Relations |
Ronnie Andrews | President and Chief Executive Officer |
Anish John | Chief Financial Officer |
David Westenberg | Piper Sandler |
Mike Mattson | Needham & Company |
Mason Carrico | Stephens |
Good day, and welcome to the OncoCyte Conference Call to discuss the Second Quarter 2022 Financial Results. Today's call is being recorded. At this time, I would like to turn the call over to Caroline Corner, Westwicke, Investor Relations. Please go ahead.
Thank you, operator, and thank you, everyone, for joining us on today's conference call to discuss OncoCyte's second quarter of 2022 financial results.